217 related articles for article (PubMed ID: 27175717)
1. Flibanserin (Addyi) for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Holt H; Tingen J
Am Fam Physician; 2016 May; 93(10):826-8. PubMed ID: 27175717
[No Abstract] [Full Text] [Related]
2. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
3. Flibanserin: a potential treatment for Hypoactive Sexual Desire Disorder in premenopausal women.
Clayton AH; Dennerstein L; Pyke R; Sand M
Womens Health (Lond); 2010 Sep; 6(5):639-53. PubMed ID: 20887163
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
5. Flibanserin and Female Sexual Desire.
Fantasia HC
Nurs Womens Health; 2016; 20(3):309-14. PubMed ID: 27287358
[TBL] [Abstract][Full Text] [Related]
6. Flibanserin and its discontents.
Aftab A; Chen C; McBride J
Arch Womens Ment Health; 2017 Apr; 20(2):243-247. PubMed ID: 27858170
[TBL] [Abstract][Full Text] [Related]
7. Is Flibanserin Meaningfully Superior to Placebo?
Clayton AH; Pyke RE
J Sex Marital Ther; 2017 Apr; 43(3):218-222. PubMed ID: 28075707
[No Abstract] [Full Text] [Related]
8. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
9. Flibanserin for Premenopausal Hypoactive Sexual Desire Disorder: Pooled Analysis of Clinical Trials.
Simon JA; Thorp J; Millheiser L
J Womens Health (Larchmt); 2019 Jun; 28(6):769-777. PubMed ID: 30707049
[No Abstract] [Full Text] [Related]
10. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
11. Flibanserin for female sexual dysfunction.
Reviriego C
Drugs Today (Barc); 2014 Aug; 50(8):549-56. PubMed ID: 25187905
[TBL] [Abstract][Full Text] [Related]
12. Effect of Flibanserin Treatment on Body Weight in Premenopausal and Postmenopausal Women with Hypoactive Sexual Desire Disorder: A Post Hoc Analysis.
Kornstein SG; Simon JA; Apfel SC; Yuan J; Barbour KA; Kissling R
J Womens Health (Larchmt); 2017 Nov; 26(11):1161-1168. PubMed ID: 28817365
[TBL] [Abstract][Full Text] [Related]
13. FDA Approval of Flibanserin--Treating Hypoactive Sexual Desire Disorder.
Joffe HV; Chang C; Sewell C; Easley O; Nguyen C; Dunn S; Lehrfeld K; Lee L; Kim MJ; Slagle AF; Beitz J
N Engl J Med; 2016 Jan; 374(2):101-4. PubMed ID: 26649985
[No Abstract] [Full Text] [Related]
14. Evaluation of Flibanserin Safety: Comparison with Other Serotonergic Medications.
Kingsberg SA; McElroy SL; Clayton AH
Sex Med Rev; 2019 Jul; 7(3):380-392. PubMed ID: 30803922
[TBL] [Abstract][Full Text] [Related]
15. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study.
Thorp J; Simon J; Dattani D; Taylor L; Kimura T; Garcia M; Lesko L; Pyke R;
J Sex Med; 2012 Mar; 9(3):793-804. PubMed ID: 22239862
[TBL] [Abstract][Full Text] [Related]
16. Flibanserin for hypoactive sexual desire disorder in premenopausal women.
Clements JN; Thompson B
JAAPA; 2018 Jun; 31(6):51-53. PubMed ID: 29846316
[TBL] [Abstract][Full Text] [Related]
17. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial.
Goldfischer ER; Breaux J; Katz M; Kaufman J; Smith WB; Kimura T; Sand M; Pyke R
J Sex Med; 2011 Nov; 8(11):3160-72. PubMed ID: 21933348
[TBL] [Abstract][Full Text] [Related]
18. Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women.
Dhanuka I; Simon JA
Expert Opin Pharmacother; 2015; 16(16):2523-9. PubMed ID: 26395164
[TBL] [Abstract][Full Text] [Related]
19. Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.
Fisher WA; Pyke RE
Sex Med Rev; 2017 Oct; 5(4):445-460. PubMed ID: 28666836
[TBL] [Abstract][Full Text] [Related]
20. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]